Table 2.
Overview of oxysterol sources and role in the CNS.
| Oxysterol | Primary source/production | Enzymes | Key receptors | Protective/homeostatic roles | Toxic/pathological effects in the CNS | References |
|---|---|---|---|---|---|---|
| Cholesterol |
|
Oxysterol precursor | LDLR, LRP1 |
|
|
Dietschy and Turley (2004), Pfrieger and Ungerer (2011) |
| 24S-hydroxycholesterol (24S-OHC) |
|
CYP46A1 | LXRα/β; NMDA receptors |
|
|
Lund et al. (1999), Björkhem et al. (2009), Testa et al. (2016) |
| 7α-hydroxycholesterol (7α-OHC) |
|
CYP7B1 | LXRα/β |
|
|
Russell (2003), Björkhem and Meaney (2004) |
| 27-hydroxycholesterol (27-OHC) |
|
CYP27A1 | LXRα/β; ERα |
|
|
Heverin et al. (2005), Björkhem et al. (2009), Hughes et al. (2013) |
| 25-hydroxycholesterol (25-OHC) |
|
CH25H | LXRα/β |
|
|
Bauman et al. (2009), Cyster et al. (2014) |
| 7β-hydroxycholesterol (7β-OHC) |
|
Non-enzymatic | Interacts with a variety of cellular receptors and pathways to exert its effects |
|
|
Poli et al. (2013), Testa et al. (2016) |
| 7-ketocholesterol (7-KC) |
|
Non-enzymatic | Interacts with several established nuclear receptors and other protein targets, particularly microglia |
|
|
Véjux and Lizard (2009), Anderson et al. (2020), Testa et al. (2016) |
Conceptual takeaway: Oxysterols act as context-dependent lipid signals in the CNS, integrating cholesterol metabolism with receptor-mediated transcriptional, synaptic, and immune pathways. Enzymatically produced oxysterols primarily support cholesterol homeostasis and neuronal function, whereas oxysterols generated during inflammation or oxidative stress accumulate to drive neurotoxicity, neuroinflammation, and myelin dysfunction, thereby linking metabolic imbalance to neurodegenerative disease.